These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1001 related articles for article (PubMed ID: 25641759)

  • 1. DYRK1A mutations in two unrelated patients.
    Ruaud L; Mignot C; Guët A; Ohl C; Nava C; Héron D; Keren B; Depienne C; Benoit V; Maystadt I; Lederer D; Amsallem D; Piard J
    Eur J Med Genet; 2015 Mar; 58(3):168-74. PubMed ID: 25641759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
    Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
    Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report of novel DYRK1A mutations in 2 individuals with syndromic intellectual disability and a review of the literature.
    Luco SM; Pohl D; Sell E; Wagner JD; Dyment DA; Daoud H
    BMC Med Genet; 2016 Feb; 17():15. PubMed ID: 26922654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID.
    van Bon BW; Coe BP; Bernier R; Green C; Gerdts J; Witherspoon K; Kleefstra T; Willemsen MH; Kumar R; Bosco P; Fichera M; Li D; Amaral D; Cristofoli F; Peeters H; Haan E; Romano C; Mefford HC; Scheffer I; Gecz J; de Vries BB; Eichler EE
    Mol Psychiatry; 2016 Jan; 21(1):126-32. PubMed ID: 25707398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies.
    Ji J; Lee H; Argiropoulos B; Dorrani N; Mann J; Martinez-Agosto JA; Gomez-Ospina N; Gallant N; Bernstein JA; Hudgins L; Slattery L; Isidor B; Le Caignec C; David A; Obersztyn E; Wiśniowiecka-Kowalnik B; Fox M; Deignan JL; Vilain E; Hendricks E; Horton Harr M; Noon SE; Jackson JR; Wilkens A; Mirzaa G; Salamon N; Abramson J; Zackai EH; Krantz I; Innes AM; Nelson SF; Grody WW; Quintero-Rivera F
    Eur J Hum Genet; 2015 Nov; 23(11):1473-81. PubMed ID: 25944381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DYRK1A pathogenic variants in two patients with syndromic intellectual disability and a review of the literature.
    Meissner LE; Macnamara EF; D'Souza P; Yang J; Vezina G; ; Ferreira CR; Zein WM; Tifft CJ; Adams DR
    Mol Genet Genomic Med; 2020 Dec; 8(12):e1544. PubMed ID: 33159716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zebrafish knockout of Down syndrome gene,
    Kim OH; Cho HJ; Han E; Hong TI; Ariyasiri K; Choi JH; Hwang KS; Jeong YM; Yang SY; Yu K; Park DS; Oh HW; Davis EE; Schwartz CE; Lee JS; Kim HG; Kim CH
    Mol Autism; 2017; 8():50. PubMed ID: 29021890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.
    Møller RS; Kübart S; Hoeltzenbein M; Heye B; Vogel I; Hansen CP; Menzel C; Ullmann R; Tommerup N; Ropers HH; Tümer Z; Kalscheuer VM
    Am J Hum Genet; 2008 May; 82(5):1165-70. PubMed ID: 18405873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of pathogenic mutations in the DYRK1A gene in patients with developmental disorders.
    Evers JM; Laskowski RA; Bertolli M; Clayton-Smith J; Deshpande C; Eason J; Elmslie F; Flinter F; Gardiner C; Hurst JA; Kingston H; Kini U; Lampe AK; Lim D; Male A; Naik S; Parker MJ; Price S; Robert L; Sarkar A; Straub V; Woods G; Thornton JM; ; Wright CF
    Hum Mol Genet; 2017 Feb; 26(3):519-526. PubMed ID: 28053047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular Phenotype Associated with
    Méjécase C; Way CM; Owen N; Moosajee M
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures.
    Fenster R; Ziegler A; Kentros C; Geltzeiler A; Green Snyder L; Brooks E; Chung WK
    Am J Med Genet A; 2022 Jul; 188(7):1954-1963. PubMed ID: 35285131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB2 zinc-finger missense mutations lead to hypomorphic alleles and a mild Mowat-Wilson syndrome.
    Ghoumid J; Drevillon L; Alavi-Naini SM; Bondurand N; Rio M; Briand-Suleau A; Nasser M; Goodwin L; Raymond P; Yanicostas C; Goossens M; Lyonnet S; Mowat D; Amiel J; Soussi-Yanicostas N; Giurgea I
    Hum Mol Genet; 2013 Jul; 22(13):2652-61. PubMed ID: 23466526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Identification of a de novo interstitial 21q22.12q22.13 deletion in a patient with intellectual disability].
    Peng Y; Jia Z; Pang J; Hu J; Xi H; Wang H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Jul; 36(7):704-707. PubMed ID: 31302916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing is necessary to clarify ID/DD cases with de novo copy number variants of uncertain significance: Two proof-of-concept examples.
    Giorgio E; Ciolfi A; Biamino E; Caputo V; Di Gregorio E; Belligni EF; Calcia A; Gaidolfi E; Bruselles A; Mancini C; Cavalieri S; Molinatto C; Cirillo Silengo M; Ferrero GB; Tartaglia M; Brusco A
    Am J Med Genet A; 2016 Jul; 170(7):1772-9. PubMed ID: 27108886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of a human induced pluripotent stem cell line (FDCHi012-A) from a patient with DYRK1A-related intellectual disability syndrome carrying DYRK1A mutation (c.1024G > T).
    Ge Y; Cheng Y; Yin T; Peng X; Xiong Z; Wu B; Wang H; Xiong M; Zhou W
    Stem Cell Res; 2024 Apr; 76():103345. PubMed ID: 38382213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel de novo heterozygous DYRK1A mutation causes complete loss of DYRK1A function and developmental delay.
    Lee KS; Choi M; Kwon DW; Kim D; Choi JM; Kim AK; Ham Y; Han SB; Cho S; Cheon CK
    Sci Rep; 2020 Jun; 10(1):9849. PubMed ID: 32555303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delineation of the KIAA2022 mutation phenotype: two patients with X-linked intellectual disability and distinctive features.
    Kuroda Y; Ohashi I; Naruto T; Ida K; Enomoto Y; Saito T; Nagai J; Wada T; Kurosawa K
    Am J Med Genet A; 2015 Jun; 167(6):1349-53. PubMed ID: 25900396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical manifestations of the deletion of Down syndrome critical region including DYRK1A and KCNJ6.
    Yamamoto T; Shimojima K; Nishizawa T; Matsuo M; Ito M; Imai K
    Am J Med Genet A; 2011 Jan; 155A(1):113-9. PubMed ID: 21204217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
    Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
    Mol Autism; 2019; 10():35. PubMed ID: 31649809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.